Skip to content
ClinCalc Pro
Menu
Emergency Medicine General Medicine Anaesthesia / Critical Care Strong — Sepsis-3 consensus definition

qSOFA Score for Sepsis

Quick bedside screen for sepsis-related organ dysfunction outside ICU

Used in: Sepsis

How to use & interpret

qSOFA is a rapid bedside prompt that flags patients with suspected infection who are at higher risk of poor outcomes (death or prolonged ICU stay). It scores one point each for respiratory rate ≥22, systolic BP ≤100 mmHg, and altered mentation (GCS <15).

A qSOFA ≥2 should prompt escalation, senior review and consideration of organ-dysfunction assessment, but it is a screening trigger, not a diagnosis of sepsis, and it is relatively insensitive for early sepsis. In UK practice NEWS2 is preferred for deterioration screening; qSOFA is best used to raise suspicion, not to rule sepsis out.

Score interpretation

Low Risk 0–1

qSOFA 0–1: Low risk of sepsis-related organ dysfunction

→ Standard clinical assessment; reassess if clinical concern remains

High Risk 2–3

qSOFA ≥2: High risk of sepsis-related organ dysfunction (in-hospital mortality >10%)

→ Initiate Sepsis-6; IV access; blood cultures; IV antibiotics within 1 hour; lactate; fluid resuscitation

Interpretation bands for the qSOFA. Apply clinical judgement and local guidance.

Frequently asked questions

Is a qSOFA under 2 reassuring?

Not reliably — qSOFA misses many patients with early sepsis. Do not use it to exclude sepsis; combine clinical judgement with NEWS2 and lactate.

References

Related

Curated clinical cross-links plus same-class fallbacks.

📚 MRCEM Revision

Featured in these MRCEM clinical pathways

The qSOFA is covered in detail — with RCEM/NICE evidence base, indications and pitfalls — in the following exam-focused pathways on our sister siteReviseMRCEM.

MRCEM Primary / Intermediate / OSCE candidates: each pathway includes exam-style questions, RCEM/NICE citations, and FAQ summaries.

Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.